The Battery Interface Genome – Materials Acceleration Platform (BIG-MAP) project is part of the large-scale and long-term European research initiative BATTERY 2030+. Here, we propose a radical paradigm shift in battery innovation, which will lead to a dramatic speed-up in the battery discovery and innovation time; reaching a 5-10 fold increase relative to the current rate of discovery within the next 5-10 years. BIG-MAP relies on the development of a unique R&D infrastructure and accelerated methodology that unites and integrates insights from leading experts, competences and data across the entire battery (discovery) value chain with Artificial Intelligence (AI), High Performance Computing (HPC), large-scale and high-throughput characterization and and autonomous synthesis robotics. In short, BIG-MAP aims to reinvent the way we invent batteries and to develop core modules and Key Demonstrators of a Materials Acceleration Platform specifically designed for accelerated discovery of battery materials and interfaces.
This will not be achievable in the three years of this project, but the BIG-MAP consortium has identified a set of Specific Objectives and 12 Key Demonstrators for the 3-year ramp-up phase that will develop and demonstrate the infrastructural backbone needed to achieve a 5-10 fold acceleration in the discovery process. In summary, the specific objectives are:
Within BIG-MAP, CIDETEC will participate in:
Hasiera: 01 | 09 | 2020
Amaiera: 31 | 08 | 2023
Aurrekontua: 20.000.000 €
The Technical University of Denmark (DTU) (coordinator)
Dassault Systèmes
BASF
CEA
Chalmers
CIDETEC Energy Storage
CNR-NANO
CNRS
ICMAB
EMIRI
EPFL
ESRF
Fraunhofer ISC
FZ Jülich
ILL
IT University of Copenhagen
KIT
NIC
PDT
Saft
SINTEF
Solvay
SOLEIL
TU Delft
University of Liverpool
Umicore
UNIVIE
University of Cambridge
University of Oxford
Uppsala University
Warsaw University of Technology
University of Münster
Finantzatzaile
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 957189.